47.98
-0.97%
Close of 9 Nov 2026, in NZD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Fisher & Paykel Healthcare Corporation
Its shares trade on NZX under the ticker FPH.NZ. It has been listed since 13 November 2001. In the fiscal year to 31 March 2026, it reported revenue of NZD 2.36bn and net income of NZD 471.9m. At that date it held total assets of NZD 2.87bn and shareholders' equity of NZD 2.13bn.
Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 13 Nov 2001
- Employees
- 5,081
- Website
- fphcare.com ↗
Leadership
Pay as last reported
- Mr. Neville MitchellNon-Executive Independent Chairman of the BoardNZD 220,744
- Mr. Lewis GradonChief Executive Officer, Managing Director, Executive Director, since 2001NZD 3.5m
- Ms. Lyndal YorkChief Financial Officer
- Mr. Andy NiccolChief Operating Officer
- Mr. Justin CallahanVice President of Sales and Marketing
- Ms. Nicola TalbotVice President - Human Resources
- Mr. Marcus DrillerVice President - Corporate
- Mr. Winston FongVice President - Surgical Technologies
- Mr. Nicholas FourieVice President – Information and Communication Technology
- Mr. Jonti RhodesVice President - Supply Chain, Facilities and Sustainability
- Mr. Brian SchultzVice President - Quality and Regulatory Affairs
- Dr. Andrew Robert SomervellVice President - Products and Technology
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 84
- Environment
- 74
- Social
- 99
- Governance
- 78
- Direct emissions (scope 1)
- 2,295 t
- Energy emissions (scope 2)
- 13,232 t
- Value chain emissions (scope 3)
- 266,044 t
- Women in the workforce
- 55%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Fisher & Paykel Healthcare Corporation Ltd has a strong brand reputation in the medical devices industry, known for high-quality and innovative products.
- The company has a diversified product portfolio, offering a wide range of respiratory care and sleep apnea products, which helps in capturing different market segments.
- Fisher & Paykel Healthcare has a global distribution network, allowing it to reach customers in various countries and regions around the world.
Weaknesses
- One weakness of Fisher & Paykel Healthcare is its reliance on third-party suppliers for certain components and raw materials, which may lead to supply chain disruptions or quality control issues.
- The company faces intense competition from other global medical device manufacturers, which poses a challenge in terms of maintaining market share and profitability.
- Fisher & Paykel Healthcare's pricing strategy for its premium products may limit market penetration in price-sensitive regions.
Opportunities
- The increasing global prevalence of respiratory diseases and sleep apnea presents a significant opportunity for Fisher & Paykel Healthcare to expand its customer base and increase sales.
- The growing aging population in many countries creates a potential market for Fisher & Paykel Healthcare's products, as older individuals are more prone to respiratory issues and require medical equipment.
- Advancements in technology and increasing focus on telehealth and remote patient monitoring open doors for Fisher & Paykel Healthcare to develop innovative solutions and tap into new markets.
Threats
- Fisher & Paykel Healthcare faces the risk of stricter regulations and compliance requirements in the medical device industry, which may increase costs and impact product development timelines.
- The ongoing COVID-19 pandemic has disrupted healthcare systems worldwide, leading to uncertainties in demand and potential supply chain challenges.
- Competitive pressures from new entrants or existing rivals who can imitate or offer similar products and technologies may threaten Fisher & Paykel Healthcare's market position.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.